Global Information
회사소개 | 문의 | 위시리스트

세계의 마이크로플루이딕 면역측정 시장 : 랩온칩, POC 분석기, 시약, 어세이

Microfluidic Immunoassay Market by Product Type (Lab-on-chip, POC Analyzers, Reagents and Assay), Technology, Application (Cardiac, Troponin, BNP) - Global Forecast to 2025

리서치사 Meticulous Market Research Pvt. Ltd.
발행일 2019년 09월 상품 코드 911029
페이지 정보 영문 207 Pages
가격
US $ 4,675 ₩ 5,510,000 PDF by E-mail (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄는 1회에 한해 가능하며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 6,175 ₩ 7,279,000 PDF by E-mail (Multi User License) help
동일 사업장 내 5명까지 공유하여 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄는 5회에 한해 가능하며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 8,175 ₩ 9,636,000 PDF by E-mail (Corporate User License) help
동일 기업의 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없으며, PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.

주의 : 본 보고서는 라이선스에 따라 자료 이용 및 인쇄 등에 제약이 있을 수 있습니다. 자세한 내용은 라이선스 설명문( )을 참고하여 주시기 바랍니다.



세계의 마이크로플루이딕 면역측정 시장 : 랩온칩, POC 분석기, 시약, 어세이 Microfluidic Immunoassay Market by Product Type (Lab-on-chip, POC Analyzers, Reagents and Assay), Technology, Application (Cardiac, Troponin, BNP) - Global Forecast to 2025
발행일 : 2019년 09월 페이지 정보 : 영문 207 Pages

세계의 마이크로플루이딕 면역측정(Microfluidic Immunoassay) 시장을 조사했으며, 시장 정의와 개요, 시장 성장에 대한 각종 영향요인 및 시장 기회 분석, 공급망, 규제 상황, 제품 종류·기술·용도·지역/국가별 동향, 시장 규모 추정과 예측, 경쟁 상황, 주요 기업 개요 등을 정리했습니다.

제1장 서론

제2장 조사 방법

제3장 주요 요약

제4장 시장 분석

  • 서론
  • 시장 역학
    • 성장 촉진요인
    • 성장 억제요인
    • 시장 기회
    • 과제
  • 공급망 분석
  • 시장 점유율 분석
  • 규제 상황 : 지역별
  • 가격 분석

제5장 정량적 POC 면역측정 진단 시장 분석과 예측 : 제품 종류별

  • 서론
  • 랩온칩/마이크로플루이딕 진단
    • 마이크로플루이딕 분석기
    • 마이크로플루이딕 카트리지
  • 기타
    • POC 분석기
    • 시약, 어세이

제6장 정량적 POC 임상 면역측정 진단 시장 분석과 예측 : 기술별

  • 서론
  • POC 랩온칩 기술
    • 전기화학적 LOC POC 기술
    • 광학적 POC 랩온칩 기술
  • 정량적 비LOC POC 기술

제7장 마이크로플루이딕 POC 면역측정 진단 시장 분석과 예측 : 용도별

  • 서론
  • 심장 바이오마커 검출
    • 싱글 바이오마커 어세이
      • 트로포닌
      • BNP(Brain Natriuretic Peptide)
      • 기타
    • 다중화(패널) 어세이
  • 염증 바이오마커 검출
  • 기타 바이오마커
  • 새로운 바이오마커

제8장 지역 및 주요 국가의 분석

  • 서론
  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 독일
    • 프랑스
    • 영국
    • 이탈리아
    • 스페인
    • 기타
  • 아시아태평양
    • 일본
    • 중국
    • 인도
    • 기타
  • 기타 지역
    • 라틴아메리카
    • 중동 및 아프리카

제9장 경쟁 상황

  • 경쟁 벤치마킹
  • 정량적 POC 면역측정 진단 제품

제10장 기업 개요

  • Abaxis, Inc.
  • Nanomix, Inc.
  • Abbott Laboratories
  • Koninklijke Philips N.V.
  • Biosurfit Sa
  • Micropoint Bioscience, Inc.
  • Siloam Biosciences, Inc.
  • NanoEnTek Inc.
  • Opko Health, Inc.
  • Quidel Corporation

제11장 부록

KSM 19.09.25

List of Tables

  • Table 1 Global Quantitative POC Clinical Immunoassay Diagnostics Market Drivers: Impact Analysis
  • Table 2 Global Quantitative POC Clinical Immunoassay Diagnostics Market Restraints: Impact Analysis
  • Table 3 Raw Material Suppliers for LOC POC Devices
  • Table 4 Contract Manufacturing Organizations (CMO) for LOC POC Devices
  • Table 5 OEMS for LOC POC Devices
  • Table 6 End-Users for LOC POC Devices
  • Table 7 Policy/Guidelines/Standards for POCT Devices in Europe
  • Table 8 POC Regulations in Asia-Pacific
  • Table 9 POC Regulations in Rest of the World
  • Table 10 Cost Comparison: LOC POC Test Vs Central Lab Test
  • Table 11 Price Comparison: Single and Multiple Analyte Tests
  • Table 12 Quantitative POC Immunoassay Diagnostics Market Size, by Product Type, 2017-2025 ($Million)
  • Table 13 Global Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017-2025 ($Million)
  • Table 14 Global Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017-2025 (Thousand Units)
  • Table 15 Global Lab-On-Chip/ Microfluidic Diagnostics Market Size, by Country/Region, 2017-2025 ($Million)
  • Table 16 Examples of Microfluidic-Based Analyzers
  • Table 17 Global Microfluidic Analyzers Market Size, by Country/Region, 2017-2025 ($Million)
  • Table 18 Global Microfluidic Analyzers Market Size, by Country/Region, 2017-2025 (Thousand Units)
  • Table 19 Advantages and Limitations of Substrate Materials
  • Table 20 Examples of Commercially Available Microfluidic-Based Cartridges
  • Table 21 Global Cartridges Market Size, by Country/Region, 2017-2025 ($Million)
  • Table 22 Global Microfluidic Cartridges Market Size, by Country/Region, 2017-2025 (Thousand Units)
  • Table 23 Global Other Quantifiable Point of Care Diagnostics Market Size, by Type, 2017-2025 ($Million)
  • Table 24 Global Other Quantifiable Point of Care Diagnostics Market Size, by Country/Region, 2017-2025 ($Million)
  • Table 25 Examples of Commercially Available POC Analyzers
  • Table 26 Global Market Size for Other POC Analyzers, by Country/Region, 2017-2025 ($Million)
  • Table 27 Examples of Commercially Available Non-LOC POC Assays
  • Table 28 Global Reagents and Assays Market Size, by Country/Region, 2017-2025 ($Million)
  • Table 29 Quantitative Point of Care Immunoassay Diagnostics Market, by Technology, 2017-2025 ($Million)
  • Table 30 Detection Technologies Used in Commercial Microfluidic POC Devices
  • Table 31 Global LOC POC Technology Market Size, by Type, 2017-2025 ($Million)
  • Table 32 Global LOC POC Technology Market Size, by Country/Region, 2017-2025 ($Million)
  • Table 33 Global Electrochemical LOC POC Technology Market Size, by Country/Region, 2017-2025 ($Million)
  • Table 34 OPTO-Microfluidic Detection Methods
  • Table 35 Global Optical LOC POC Technology Market Size, by Country/Region, 2017-2025 ($Million)
  • Table 36 Technologies Used in Commercial Quantitative Non-LOC POC Devices
  • Table 37 Global Non-LOC Point of Care Technology Market Size, by Country/Region, 2017-2025 ($Million)
  • Table 38 Global Quantitative POC Immunoassay Diagnostics Market Size, by Application, 2017-2025 ($Million)
  • Table 39 Global Microfluidic POC Market Size for Cardiac Biomarkers, by Assay Type, 2017 - 2025 ($Million)
  • Table 40 Global Microfluidic POC Market Size for Cardiac Biomarkers, by Country/Region, 2017-2025 ($Million)
  • Table 41 Commercially Available Tests for Single Cardiac Biomarker Detection
  • Table 42 Global Microfluidic POC Market Size for Single Biomarker Assay, by Type, 2017-2025 ($Million)
  • Table 43 Global Microfluidic POC Market Size for Single Cardiac Biomarker Assay, by Country/Region, 2017-2025 ($Million)
  • Table 44 Global Microfluidic POC Market Size for Troponin Assay, by Country/Region, 2017 - 2025 ($Million)
  • Table 45 Global Microfluidic POC Market Size for BNP Assays, by Country/Region, 2017 - 2025 ($Million)
  • Table 46 Global Microfluidic POC Market Size for Other Cardiac Biomarkers, by Country/Region, 2017 - 2025 ($Thousand)
  • Table 47 Commercially Available Tests for Multiplexed Cardiac Assays
  • Table 48 Global Microfluidic POC Market Size for Multiplexed Cardiac Assay, by Country/Region, 2017-2025 ($Million)
  • Table 49 Global Microfluidic POC Market Size for inflammatory Biomarkers, by Country/Region, 2017-2025 ($Million)
  • Table 50 Tests/Devices for Hba1c and Glucose Detection
  • Table 51 Clinically Significant Tumor Markers
  • Table 52 Global LOC POC Immunodiagnostics Market Size for Other Biomarkers, by Country/Region, 2017-2025 ($Thousand)
  • Table 53 Emerging Biomarkers
  • Table 54 Global POC Immunoassay Diagnostics Market Size, by Country/Region, 2017-2025 ($Million)
  • Table 55 North America: Quantitative POC Immunoassay Diagnostics Market Size, by Country, 2017 - 2025 ($Million)
  • Table 56 North America: Microfluidic POC Immunoassay Diagnostics Market, by Country, 2017 - 2025 ($Million)
  • Table 57 North America: Quantitative POC Immunoassay Diagnostics Market Size, by Product Type, 2017 - 2025 ($Million)
  • Table 58 North America: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 - 2025 ($Million)
  • Table 59 North America: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 - 2025 (Thousand Units)
  • Table 60 North America: Other Quantifiable POC Diagnostics Market Size, by Type, 2017 - 2025 ($Million)
  • Table 61 North America: Quantitative POC Immunoassay Diagnostics Market Size, by Technology, 2017 - 2025 ($Million)
  • Table 62 North America: Microfluidic POC Technologies Market Size, by Type, 2017 - 2025 ($Million)
  • Table 63 North America: Microfluidic POC Immunoassay Diagnostics Market Size, by Application, 2017 - 2025 ($Million)
  • Table 64 North America: Microfluidic POC Market size for Cardiac Biomarker Detection, by Type, 2017 - 2025 ($Million)
  • Table 65 North America: Microfluidic POC Market Size for Single Biomarker Detection, by Type, 2017 - 2025 ($Million)
  • Table 66 U.S.: Quantitative POC Clinical Immunoassay Diagnostics Market Size, by Product Type, 2017 - 2025 ($Million)
  • Table 67 U.S.: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 - 2025 ($Million)
  • Table 68 U.S.: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 - 2025 (Thousand Units)
  • Table 69 U.S.: Other Quantifiable POC Diagnostics Market Size, by Type, 2017 - 2025 ($Million)
  • Table 70 U.S.: Quantitative POC Immunoassay Diagnostics Market Size, by Technology, 2017 - 2025 ($Million)
  • Table 71 U.S.: Microfluidic POC Technologies Market Size, by Type, 2017 - 2025 ($Million)
  • Table 72 U.S.: Microfluidic POC Immunoassay Diagnostics Market Size, by Application, 2017 - 2025 ($Million)
  • Table 73 U.S.: Microfluidic POC Market size for Cardiac Biomarkers, by Assay Type, 2017 - 2025 ($Million)
  • Table 74 U.S.: Microfluidic POC Market Size for Single Cardiac Biomarker, by Type, 2017 - 2025 ($Million)
  • Table 75 Canada: Quantitative POC Immunoassay Diagnostics Market Size, by Product Type, 2017 - 2025 ($Million)
  • Table 76 Canada: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 - 2025 ($Million)
  • Table 77 Canada: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 - 2025 (Thousand Units)
  • Table 78 Canada: Other Quantifiable POC Diagnostics Market Size, by Type, 2017 - 2025 ($Million)
  • Table 79 Canada: Quantitative POC Immunoassay Diagnostics Market Size, by Technology, 2017 - 2025 ($Million)
  • Table 80 Canada: Microfluidic POC Technologies Market Size, by Type, 2017 - 2025 ($Million)
  • Table 81 Canada: Microfluidic POC Immunoassay Diagnostics Market Size, by Application, 2017 - 2025 ($Million)
  • Table 82 Canada: Microfluidic POC Market Size for Cardiac Biomarkers, by Type, 2017 - 2025 ($Million)
  • Table 83 Canada: Microfluidic POC Market Size for Single Biomarker, by Type, 2017 - 2025 ($Million)
  • Table 84 Europe: Quantitative POC Immunoassay Diagnostics Market Size, by Country, 2017-2025 ($Million)
  • Table 85 Europe: Microfluidic POC Immunoassay Diagnostics Market Size, by Country, 2017 - 2025 ($Million)
  • Table 86 Europe: Quantitative POC Clinical Immunoassay Diagnostics Market Size, by Product Type, 2017 - 2025 ($Million)
  • Table 87 Europe: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 - 2025 ($Million)
  • Table 88 Europe: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 - 2025 (Thousand Units)
  • Table 89 Europe: Other Quantifiable POC Diagnostics Market Size, by Type, 2017 - 2025 ($Million)
  • Table 90 Europe: Quantitative POC Immunoassay Diagnostics Market Size, by Technology, 2017 - 2025 ($Million)
  • Table 91 Europe: Microfluidic POC Technologies Market Size, by Type, 2017 - 2025 ($Million)
  • Table 92 Europe: Microfluidic POC Immunoassay Diagnostics Market Size, by Application, 2017 - 2025 ($Million)
  • Table 93 Europe: Microfluidic POC Market Size for Cardiac Biomarkers, by Assay Type, 2017 - 2025 ($Million)
  • Table 94 Europe: Microfluidic POC Market Size for Single Biomarkers, by Type, 2017 - 2025 ($Million)
  • Table 95 Germany: Quantitative POC Clinical Immunoassay Diagnostics Market Size, by Product Type, 2017 - 2025 ($Million)
  • Table 96 Germany: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 - 2025 ($Million)
  • Table 97 Germany: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 - 2025 (Thousand Units)
  • Table 98 Germany: Other Quantifiable POC Diagnostics Market Size, by Type, 2017 - 2025 ($Million)
  • Table 99 Germany: Quantitative POC Immunoassay Diagnostics Market Size, by Technology, 2017 - 2025 ($Million)
  • Table 100 Germany: Microfluidic POC Technologies Market Size, by Type, 2017 - 2025 ($Million)
  • Table 101 Germany: Microfluidic POC Immunoassay Diagnostics Market Size, by Application, 2017 - 2025 ($Million)
  • Table 102 Germany: Microfluidic POC Market Size for Cardiac Biomarker Detection, by Type, 2017 - 2025 ($Million)
  • Table 103 Germany: Microfluidic POC Market Size for Single Biomarker Detection, by Type, 2017 - 2025 ($Million)
  • Table 104 France: Quantitative POC Clinical Immunoassay Diagnostics Market Size, by Product Type, 2017 - 2025 ($Million)
  • Table 105 France: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 - 2025 ($Million)
  • Table 106 France: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 - 2025 (Thousand Units)
  • Table 107 France: Other Quantifiable POC Diagnostics Market Size, by Type, 2017 - 2025 ($Million)
  • Table 108 France: Quantitative POC Immunoassay Diagnostics Market Size, by Technology, 2017 - 2025 ($Million)
  • Table 109 France: Microfluidic POC Technologies Market Size, by Type, 2017 - 2025 ($Million)
  • Table 110 France: Microfluidic POC Immunoassay Diagnostics Market Size, by Application, 2017 - 2025 ($Million)
  • Table 111 France: Microfluidic POC Market Size for Cardiac Biomarkers, by Assay Type, 2017 - 2025 ($Million)
  • Table 112 France: Microfluidic POC Market Size for Single Biomarkers, by Type, 2017 - 2025 ($Million)
  • Table 113 U.K.: Quantitative POC Clinical Immunoassay Diagnostics Market Size, by Product Type, 2017 - 2025 ($Million)
  • Table 114 U.K.: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 - 2025 ($Million)
  • Table 115 U.K.: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 - 2025 (Thousand Units)
  • Table 116 U.K.: Other Quantifiable POC Diagnostics Market Size, by Type, 2017 - 2025 ($Million)
  • Table 117 U.K.: Quantitative POC Immunoassay Diagnostics Market Size, by Technology, 2017 - 2025 ($Million)
  • Table 118 U.K.: Microfluidic POC Technologies Market Size, by Type, 2017 - 2025 ($Million)
  • Table 119 U.K.: Microfluidic POC Immunoassay Diagnostics Market Size, by Application, 2017 - 2025 ($Thousand)
  • Table 120 U.K.: Microfluidic POC Market Size for Cardiac Biomarkers, by Assay Type, 2017 - 2025 ($Million)
  • Table 121 U.K.: Microfluidic POC Market Size for Single Biomarker Detection, by Type, 2017 - 2025 ($Million)
  • Table 122 Italy: Quantitative POC Clinical Immunoassay Diagnostics Market Size, by Product Type, 2017 - 2025 ($Million)
  • Table 123 Italy: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 - 2025 ($Million)
  • Table 124 Italy: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 - 2025 (Thousand Units)
  • Table 125 Italy: Other Quantifiable POC Diagnostics Market Size, by Type, 2017 - 2025 ($Million)
  • Table 126 Italy: Quantitative POC Immunoassay Diagnostics Market Size, by Technology, 2017 - 2025 ($Million)
  • Table 127 Italy: Microfluidic POC Technologies Market Size, by Type, 2017 - 2025 ($Thousand)
  • Table 128 Italy: Microfluidic POC Immunoassay Diagnostics Market Size, by Application, 2017 - 2025 ($Thousand)
  • Table 129 Italy: Microfluidic POC Market Size for Cardiac Biomarkers, by Assay Type, 2017 - 2025 ($Million)
  • Table 130 Italy: Microfluidic POC Market Size for Single Biomarker Detection, by Type, 2017 - 2025 ($Million)
  • Table 131 Spain: Quantitative POC Clinical Immunoassay Diagnostics Market Size, by Product Type, 2017 - 2025 ($Million)
  • Table 132 Spain: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 - 2025 ($Million)
  • Table 133 Spain: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 - 2025 (Thousand Units)
  • Table 134 Spain: Other Quantifiable POC Diagnostics Market Size, by Type, 2017 - 2025 ($Million)
  • Table 135 Spain: Quantitative POC Immunoassay Diagnostics Market Size, by Technology, 2017 - 2025 ($Million)
  • Table 136 Spain: Microfluidic POC Technologies Market Size, by Type, 2017 - 2025 ($Million)
  • Table 137 Spain: Microfluidic POC Immunoassay Diagnostics Market Size, by Application, 2017 - 2025 ($Thousand)
  • Table 138 Spain: Microfluidic POC Market Size for Cardiac Biomarkers, by Assay Type, 2017 - 2025 ($Million)
  • Table 139 Spain: Microfluidic POC Market Size for Single Biomarkers, by Type, 2017 - 2025 ($Million)
  • Table 140 RoE: Quantitative POC Clinical Immunoassay Diagnostics Market Size, by Product Type, 2017 - 2025 ($Million)
  • Table 141 RoE: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 - 2025 ($Million)
  • Table 142 RoE: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 - 2025 (Thousand Units)
  • Table 143 RoE: Other Quantifiable POC Diagnostics Market Size, by Type, 2017 - 2025 ($Million)
  • Table 144 RoE: Quantitative POC Immunoassay Diagnostics Market Size, by Technology, 2017 - 2025 ($Million)
  • Table 145 RoE: Microfluidic POC Technologies Market Size, by Type, 2017 - 2025 ($Million)
  • Table 146 RoE: Microfluidic POC Immunoassay Diagnostics Market Size, by Application, 2017 - 2025 ($Million)
  • Table 147 RoE: Microfluidic POC Market Size for Cardiac Biomarkers, by Assay Type, 2017 - 2025 ($Million)
  • Table 148 RoE: Microfluidic POC Market Size for Single Biomarkers, by Type, 2017 - 2025 ($Million)
  • Table 149 APAC: Quantitative POC Immunoassay Diagnostics Market Size, by Country, 2017-2025 ($Million)
  • Table 150 APAC: Microfluidic POC Immunoassay Diagnostics Market, by Country, 2017 - 2025 ($Million)
  • Table 151 APAC: Quantitative POC Immunoassay Diagnostics Market Size, by Product Type, 2017 - 2025 ($Million)
  • Table 152 APAC: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 - 2025 ($Million)
  • Table 153 APAC: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 - 2025 (Thousand Units)
  • Table 154 APAC: Other Quantifiable POC Diagnostics Market Size, by Type, 2017 - 2025 ($Million)
  • Table 155 APAC: Quantitative POC Immunoassay Diagnostics Market Size, by Technology, 2017 - 2025 ($Million)
  • Table 156 APAC: Microfluidic POC Technologies Market Size, by Type, 2017 - 2025 ($Million)
  • Table 157 APAC: Microfluidic POC Immunoassay Diagnostics Market Size, by Application, 2017 - 2025 ($Million)
  • Table 158 APAC: Microfluidic POC Market Size for Cardiac Biomarkers, by Assay Type, 2017 - 2025 ($Million)
  • Table 159 APAC: Microfluidic POC Market Size for Single Biomarkers, by Type, 2017 - 2025 ($Million)
  • Table 160 Japan: Quantitative POC Immunoassay Diagnostics Market Size, by Product Type, 2017 - 2025 ($Million)
  • Table 161 Japan: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 - 2025 ($Million)
  • Table 162 Japan: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 - 2025 (Thousand Units)
  • Table 163 Japan: Other Quantifiable POC Diagnostics Market Size, by Type, 2017 - 2025 ($Million)
  • Table 164 Japan: Quantitative POC Immunoassay Diagnostics Market Size, by Technology, 2017 - 2025 ($Million)
  • Table 165 Japan: Microfluidic POC Technologies Market Size, by Type, 2017 - 2025 ($Million)
  • Table 166 Japan: Microfluidic POC Immunoassay Diagnostics Market Size, by Application, 2017 - 2025 ($Million)
  • Table 167 Japan: Microfluidic POC Market Size for Cardiac Biomarkers, by Assay Type, 2017 - 2025 ($Million)
  • Table 168 Japan: Microfluidic POC Market Size for Single Biomarker Detection, by Type, 2017 - 2025 ($Million)
  • Table 169 China: Quantitative POC Clinical Immunoassay Diagnostics Market Size, by Product Type, 2017 - 2025 ($Million)
  • Table 170 China: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 - 2025 ($Million)
  • Table 171 China: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 - 2025 (Thousand Units)
  • Table 172 China: Other Quantifiable POC Diagnostics Market Size, by Type, 2017 - 2025 ($Million)
  • Table 173 China: Quantitative POC Immunoassay Diagnostics Market Size, by Technology, 2017 - 2025 ($Million)
  • Table 174 China: Microfluidic POC Technologies Market Size, by Type, 2017 - 2025 ($Million)
  • Table 175 China: Microfluidic POC Immunoassay Diagnostics Market Size, by Application, 2017 - 2025 ($Million)
  • Table 176 China: Microfluidic POC Market Size for Cardiac Biomarkers, by Assay Type, 2017 - 2025 ($Million)
  • Table 177 China: Microfluidic POC Market Size for Single Biomarkers, by Type, 2017 - 2025 ($Million)
  • Table 178 India: Quantitative POC Immunoassay Diagnostics Market Size, by Product Type, 2017 - 2025 ($Million)
  • Table 179 India: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 - 2025 ($Million)
  • Table 180 India: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 - 2025 (Thousand Units)
  • Table 181 India: Other Quantifiable POC Diagnostics Market Size, by Type, 2017 - 2025 ($Million)
  • Table 182 India: Quantitative POC Immunoassay Diagnostics Market Size, by Technology, 2017 - 2025 ($Million)
  • Table 183 India: Microfluidic POC Technologies Market Size, by Type, 2017 - 2025 ($Million)
  • Table 184 India: Microfluidic POC Immunoassay Diagnostics Market Size, by Application, 2017 - 2025 ($Thousand)
  • Table 185 India: Microfluidic POC Market Size for Cardiac Biomarkers, by Assay Type, 2017 - 2025 ($Million)
  • Table 186 India: Microfluidic POC Market Size for Single Biomarkers, by Type, 2017 - 2025 ($Million)
  • Table 187 RoAPAC: Quantitative POC Clinical Immunoassay Diagnostics Market Size, by Product Type, 2017 - 2025 ($Million)
  • Table 188 RoAPAC: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 - 2025 ($Million)
  • Table 189 RoAPAC: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 - 2025 (Thousand Units)
  • Table 190 RoAPAC: Other Quantifiable POC Diagnostics Market Size, by Type, 2017 - 2025 ($Million)
  • Table 191 RoAPAC: Quantitative POC Immunoassay Diagnostics Market Size, by Technology, 2017 - 2025 ($Million)
  • Table 192 RoAPAC: Microfluidic POC Technologies Market Size, by Type, 2017 - 2025 ($Million)
  • Table 193 RoAPAC: Microfluidic POC Immunoassay Diagnostics Market Size, by Application, 2017 - 2025 ($Thousand)
  • Table 194 RoAPAC: Microfluidic POC Market Size for Cardiac Biomarkers, by Assay Type, 2017 - 2025 ($Million)
  • Table 195 RoAPAC: Microfluidic POC Market Size for Single Biomarkers, by Type, 2017 - 2025 ($Million)
  • Table 196 RoW: Quantitative POC Immunoassay Diagnostics Market, by Region, 2017-2025 ($Million)
  • Table 197 RoW: Microfluidic POC Immunoassay Diagnostics Market, by Region, 2017 - 2025 ($Million)
  • Table 198 RoW: Quantitative POC Immunoassay Diagnostics Market Size, by Product Type, 2017 - 2025 ($Million)
  • Table 199 RoW: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 - 2025 ($Million)
  • Table 200 RoW: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 - 2025 (Thousand Units)
  • Table 201 RoW: Other Quantifiable POC Diagnostics Market Size, by Type, 2017 - 2025 ($Million)
  • Table 202 RoW: Quantitative POC Immunoassay Diagnostics Market Size, by Technology, 2017 - 2025 ($Million)
  • Table 203 RoW: Microfluidic POC Technologies Market Size, by Type, 2017 - 2025 ($Million)
  • Table 204 RoW: Microfluidic POC Immunoassay Diagnostics Market Size, by Application, 2017 - 2025 ($Million)
  • Table 205 RoW: Microfluidic POC Market Size for Cardiac Biomarkers, by Assay Type, 2017 - 2025 ($Million)
  • Table 206 RoW: Microfluidic POC Market Size for Single Biomarkers, by Type, 2017 - 2025 ($Million)
  • Table 207 Latin America: Quantitative POC Clinical Immunoassay Diagnostics Market Size, by Product Type, 2017 - 2025 ($Million)
  • Table 208 Latin America: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 - 2025 ($Million)
  • Table 209 Latin America: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 - 2025 (Thousand Units)
  • Table 210 Latin America: Other Quantifiable POC Diagnostics Market Size, by Type, 2017 - 2025 ($Million)
  • Table 211 Latin America: Quantitative POC Immunoassay Diagnostics Market Size, by Technology, 2017 - 2025 ($Million)
  • Table 212 Latin America: Microfluidic POC Technologies Market Size, by Type, 2017 - 2025 ($Million)
  • Table 213 Latin America: Microfluidic POC Immunoassay Diagnostics Market Size, by Application, 2017 - 2025 ($Million)
  • Table 214 Latin America: Microfluidic POC Market Size for Cardiac Biomarkers, by Assay Type, 2017 - 2025 ($Million)
  • Table 215 Latin America: Microfluidic POC Market Size for Single Biomarkers, by Type, 2017 - 2025 ($Million)
  • Table 216 Middle East & Africa: Quantitative POC Clinical Immunoassay Diagnostics Market Size, by Product Type, 2017 - 2025 ($Million)
  • Table 217 Middle East & Africa: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 - 2025 ($Million)
  • Table 218 Middle East & Africa: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 - 2025 (Thousand Units)
  • Table 219 Middle East & Africa: Other Quantifiable POC Diagnostics Market Size, by Type, 2017 - 2025 ($Million)
  • Table 220 Middle East & Africa: Quantitative POC Immunoassay Diagnostics Market Size, by Technology, 2017 - 2025 ($Million)
  • Table 221 Middle East & Africa: Microfluidic POC Technologies Market Size, by Type, 2017 - 2025 ($Thousand)
  • Table 222 Middle East & Africa: Microfluidic POC Immunoassay Diagnostics Market Size, by Application, 2017 - 2025 ($Thousand)
  • Table 223 Middle East & Africa: Microfluidic POC Market Size for Cardiac Biomarkers, by Assay Type, 2017 - 2025 ($Million)
  • Table 224 Middle East & Africa: Microfluidic POC Market Size for Single Biomarker Detection, by Type, 2017 - 2025 ($Million)
  • Table 225 Number of Developments by the Major Players During 2016-2019
  • Table 226 Quantitative POC Immunoassay Diagnostics: Competitive Benchmarking
  • Table 227 Key Products: Quantitative POC Immunoassay Diagnostics

List of Figures

  • Figure 1 Research Process
  • Figure 2 Key Executives interviewed
  • Figure 3 Market Size Estimation of LOC POC Immunodiagnostics Market
  • Figure 4 Market Size Estimation of Other Quantifiable POC Immunodiagnostics Market
  • Figure 5 Market Size Estimation of Total POC Immunoassay Market
  • Figure 6 Key Opportunities
  • Figure 7 Key Adopters of Microfluidic POC Clinical Immunoassay Diagnostics
  • Figure 8 LOC POC Technology Will Grow Fastest and Surpass Other Quantifiable POC Immunoassay Diagnostics Market by 2025
  • Figure 9 Quantitative POC Immunoassay Diagnostics Market Overview: 2019-2025
  • Figure 10 Global LOC POC Immunoassay Diagnostics Market, by Geography, 2018
  • Figure 11 Number of Cancer Cases Across the World (In Millions)
  • Figure 12 Prevalence of Diabetes, by Region, 2003 & 2025
  • Figure 13 Number of Deaths Attributed to Cardiovascular Diseases (Global), 2013-2030 (In Millions)
  • Figure 14 Disposable Personal income in China (In USD)
  • Figure 15 Supply Chain Analysis for LOC POC Immunoassay Diagnostics Market
  • Figure 16 Global Microfluidic POC Immunoassay Diagnostic Market Share, by Key Players, 2018
  • Figure 17 Pricing Trend for LOC-Based Diagnostic Test for the U.S. and China: 2017-2025
  • Figure 18 Quantitative POC Immunoassay Diagnostics Market Size, by Product Type, 2019-2025 ($Million)
  • Figure 19 Quantitative Point of Care Clinical Immunoassay Diagnostics Market, by Technology, 2019-2025 ($Million)
  • Figure 20 Global Quantitative POC Immunoassay Diagnostics Market Size, by Application, 2019-2025 ($Million)
  • Figure 21 Global POC Immunoassay Diagnostics Market Size, by Region, 2019-2025 ($Million)
  • Figure 22 North America: Quantitative POC Immunoassay Diagnostics Market Size, by Country, 2019-2025 ($Million)
  • Figure 23 North America: Microfluidic POC Immunoassay Diagnostics Market Size, by Country, 2019-2025 ($Million)
  • Figure 24 Europe: Quantitative POC Clinical Immunoassay Diagnostics Market Size, by Country, 2019-2025 ($Million)
  • Figure 25 Europe: Microfluidic POC Clinical Immunoassay Diagnostics Market Size, by Country, 2019-2025 ($Million)
  • Figure 26 Percentage of Older People (65 Years and Above) in the France, 2000-2050
  • Figure 27 U.K.: Proportional Mortality, by Disease Type, 2014
  • Figure 28 Proportion of Elderly Population in Poland, 2000-2030 (%)
  • Figure 29 APAC: Quantitative POC Clinical Immunoassay Diagnostics Market Size, by Country, 2019-2025 ($Million)
  • Figure 30 APAC: Microfluidic POC Immunoassay Diagnostics Market Size, by Country, 2019-2025 ($Million)
  • Figure 31 Japan: Proportional Mortality, 2014
  • Figure 32 China Population Growth Chart, 2010-2040
  • Figure 33 RoW: Quantitative POC Immunoassay Diagnostics Market, by Region, 2019-2025 ($Million)
  • Figure 34 RoW: Microfluidic POC Immunoassay Diagnostics Market, by Region, 2019-2025 ($Million)
  • Figure 35 Latin America: Aging Population, 2005-2050
  • Figure 36 Growth Strategies Adopted by Key Players
  • Figure 37 Zoetis Inc.: Financial Overview (2016-2018)
  • Figure 38 Abbott Laboratories: Financial Overview (2016-2018)
  • Figure 39 Koninklijke Philips N.V.: Financial Overview (2016-2018)
  • Figure 40 NanoEnTek, Inc: Financial Overview (2015-2017)
  • Figure 41 Opko Health, Inc.: Financial Overview (2016-2018)
  • Figure 42 Quidel Corporation: Financial Overview (2016-2018)

Microfluidic Immunoassay Market by Product Type (Lab-on-chip, POC Analyzers, Reagents & Assay), Technology, Application (Cardiac, Troponin, BNP) - Global Forecast to 2025

The global microfluidic immunoassay market is expected to grow at a CAGR of 12.7% from 2019 to reach $2.0 billion by 2025. The growth in microfluidic immunoassay market is mainly attributed to greater benefits offered by LOC over conventional quantifiable technologies, growing need of POC in low-resource settings, increasing research activities in the field of microfluidic technology, high influx of venture capital funding for the development of LOC-based POC diagnostics, rapid decision making in emergency care, and rising incidence and prevalence of chronic diseases coupled with aging population. In addition, emerging economies and novel technologies such as paper-based microfluidics will further provide significant opportunities for the various stakeholders in this market. However, factors such as lengthy approval time for POC devices and reluctance of healthcare professionals to replace existing diagnostic platforms - are likely to hinder the market growth. On the other hand, selection of suitable substrate material for designing microfluidic chip; difficulty in up-scaling the process for mass production; and product-design and cost related challenges in the developing countries - are recognized as the major hurdles to overcome.

The adoption of LOC/microfluidic diagnostics is expected to grow at the fastest CAGR during the forecast year. This is attributed to its capability to scaling down whole laboratory process on a single chip and expedite the process of disease diagnosis with highly precise quantitative results.

The non-LOC POC technologies segment is estimated to command the largest share of the global microfluidic immunoassay market in 2019. The large share of this segment is attributed to a greater adoption of these technologies - over the years - for wide range of diagnostic applications. However, LOC POC technology is expected to grow at the fastest CAGR during the forecast period. This is mainly attributed to greater benefits offered by LOC over conventional POC diagnostic methods and growing research activities in this field - supported by private and public funding.

On the basis of application, the cardiac biomarker detection segment is estimated to hold the largest share of the global microfluidic immunoassay market in 2019 and is poised to grow at the fastest CAGR during the forecast period. The large share this segment is attributed to high prevalence of cardiovascular diseases, availability of large number of LOC-based products for cardiac biomarkers, and relatively greater adoption of these products among end-users.

An in-depth analysis of the geographical scenario of the microfluidic immunoassay market provides detailed qualitative and quantitative insights about the five major geographies (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa) along with the coverage of major countries in each region. North America commanded the largest share of the global microfluidic immunoassay market in 2019, followed by Europe, Asia-Pacific, Latin America, and Middle East & Africa.

The key players operating in the global microfluidic immunoassay market are Abaxis, Inc. (a subsidiary of Zoetis Inc.), Nanomix, Inc., Abbott Laboratories, Koninklijke Philips N.V., Biosurfit SA, Micropoint Bioscience, Inc., Siloam Biosciences, NanoEnTek Inc., OPKO Health, Inc., and Quidel Corporation.

Scope of the Report:

Market by Product Type

  • Lab-on-chip/microfluidic diagnostics
    • Microfluidic Analyzers
    • MicrofluidicCartridges
  • Other Quantifiable POC diagnostics
    • POC Analyzers
    • Reagents and Assays

Market by Technology

  • Point of Care Lab on Chip Technology
    • Electrochemical LOC POC Technology
    • Optical POC LOC Technology
  • Non Lab on Chip Point of Care Technology

Market by Application

  • Cardiac Biomarker Detection
    • Single Biomarker Assay
  • Troponin
  • Brain Natriuretic Peptide (BNP)
  • Other Cardiac Biomarkers
    • Multiplexed Panel Assay
  • Inflammatory Biomarker Detection
  • Other Biomarkers
  • Emerging Biomarkers

Market by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia-Pacific (APAC)
    • Japan
    • China
    • India
    • Rest of Asia-Pacific (RoAPAC)
  • Latin America
  • Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Market Ecosystem
  • 1.2. Currency and Limitations
    • 1.2.1. Currency
    • 1.2.2. Limitations
  • 1.3. Key Stakeholders

2. Research Methodology

  • 2.1. Research Process
    • 2.1.1. Secondary Research
    • 2.1.2. Primary Research
    • 2.1.3. Market Size Estimation

3. Executive Summary

4. Market insights

  • 4.1. Introduction
  • 4.2. Market Dynamics
    • 4.2.1. Market Drivers
      • 4.2.1.1. Venture Capital Funding for the Development of LOC-Based POC Diagnostics
      • 4.2.1.2. Rising Prevalence of Chronic Diseases Coupled with Aging Population
      • 4.2.1.3. Greater Benefits offered by Microfluidic/LOC Over Conventional Quantifiable Technologies
      • 4.2.1.4. Rapid Decision Making in Emergency Care
      • 4.2.1.5. Growing Need of POC Testing in Low-Resource Setting
      • 4.2.1.6. Rising Research Activities Related to Microfluidic Technology
    • 4.2.2. Market Restraints
      • 4.2.2.1. Tedious Regulatory Approval Process
      • 4.2.2.2. Reluctance of Healthcare Professionals to Replace the Existing Diagnostic Platforms
    • 4.2.3. Market Opportunities
      • 4.2.3.1. Significant Opportunities from Emerging Economies
      • 4.2.3.2. Emerging Technologies Such as Paper-Based Microfluidics - offers New Growth Avenues
    • 4.2.4. Market Challenges
      • 4.2.4.1. Selection of Suitable Substrate Material for Designing Microfluidic Chip
      • 4.2.4.2. Product-Design and Cost Related Challenges in the Developing Countries
  • 4.3. Supply Chain Analysis
  • 4.4. Market Share Analysis
  • 4.5. Regulatory Analysis
    • 4.5.1. North America
    • 4.5.2. Europe
    • 4.5.3. Asia-Pacific
    • 4.5.4. Latin America, Middle East & Africa
  • 4.6. Pricing Analysis
    • 4.6.1. Cost Comparison: POC Tests Vs Central Lab Test
    • 4.6.2. Pricing Trend for Microfluidic Tests
    • 4.6.3. Single Analyte Testing Vs Multiple Analyte Testing (Panel Testing) in Microfluidic Detection

5. Quantitative POC Immunoassay Diagnostics Market, by Product Type

  • 5.1. Introduction
  • 5.2. Lab-On-Chip/Microfluidic Diagnostics
    • 5.2.1. Microfluidic Analyzers
    • 5.2.2. Microfluidic Cartridges
  • 5.3. Other Quantifiable Point of Care Diagnostics
    • 5.3.1. POC Analyzers
    • 5.3.2. Reagents and Assays

6. Quantitative Point of Care Clinical Immunoassay Diagnostics Market, by Technology ($Value)

  • 6.1. Introduction
  • 6.2. Point-of-Care Lab-On-Chip Technology
    • 6.2.1. Electrochemical LOC POC Technology
    • 6.2.2. Optical Point-of-Care Lab-On-Chip Technology
  • 6.3. Quantitative Non-LOC POC Technology

7. Microfluidic POC Immunoassay Diagnostics Market, by Application ($Value)

  • 7.1. Introduction
  • 7.2. Cardiac Biomarker Detection
    • 7.2.1. Single Biomarker Assay
      • 7.2.1.1. Troponin
      • 7.2.1.2. Brain Natriuretic Peptide (BNP)
      • 7.2.1.3. Other Cardiac Biomarkers
    • 7.2.2. Multiplexed (Panel) Assay
  • 7.3. Inflammatory Biomarker Detection
  • 7.4. Other Biomarkers
  • 7.5. Emerging Biomarkers

8. Geographic Analysis

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. U.S.
    • 8.2.2. Canada
  • 8.3. Europe
    • 8.3.1. Germany
    • 8.3.2. France
    • 8.3.3. U.K.
    • 8.3.4. Italy
    • 8.3.5. Spain
    • 8.3.6. Rest of Europe (RoE)
  • 8.4. Asia-Pacific (APAC)
    • 8.4.1. Japan
    • 8.4.2. China
    • 8.4.3. India
    • 8.4.4. Rest of Asia Pacific (RoAPAC)
  • 8.5. Rest of the World (RoW)
    • 8.5.1. Latin America (LATAM)
    • 8.5.2. Middle East and Africa

9. Competitive Landscape

  • 9.1. Competitive Benchmarking
  • 9.2. Quantitative POC Immunoassay Diagnostics Products

10. Company Profiles

  • 10.1. Abaxis, Inc. (A Subsidiary of Zoetis Inc.)
    • 10.1.1. Business Overview
    • 10.1.2. Financial Overview
    • 10.1.3. Product Portfolio
    • 10.1.4. Strategic Developments
  • 10.2. Nanomix, Inc.
    • 10.2.1. Business Overview
    • 10.2.2. Financial Overview
    • 10.2.3. Product Portfolio
    • 10.2.4. Strategic Developments
  • 10.3. Abbott Laboratories (Including Alere)
    • 10.3.1. Business Overview
    • 10.3.2. Financial Overview
    • 10.3.3. Product Portfolio
    • 10.3.4. Strategic Developments
  • 10.4. Koninklijke Philips N.V.
    • 10.4.1. Business Overview
    • 10.4.2. Financial Overview
    • 10.4.3. Product Portfolio
    • 10.4.4. Strategic Developments
  • 10.5. Biosurfit Sa
    • 10.5.1. Business Overview
    • 10.5.2. Financial Overview
    • 10.5.3. Product Portfolio
    • 10.5.4. Strategic Developments
  • 10.6. Micropoint Bioscience, Inc.
    • 10.6.1. Business Overview
    • 10.6.2. Financial Overview
    • 10.6.3. Product Portfolio
    • 10.6.4. Strategic Developments
  • 10.7. Siloam Biosciences, Inc.
    • 10.7.1. Business Overview
    • 10.7.2. Financial Overview
    • 10.7.3. Product Portfolio
    • 10.7.4. Strategic Developments
  • 10.8. NanoEnTek Inc.
    • 10.8.1. Business Overview
    • 10.8.2. Financial Overview
    • 10.8.3. Product Portfolio
    • 10.8.4. Strategic Developments
  • 10.9. Opko Health, Inc.
    • 10.9.1. Business Overview
    • 10.9.2. Financial Overview
    • 10.9.3. Product Portfolio
    • 10.9.4. Strategic Developments
  • 10.10. Quidel Corporation
    • 10.10.1. Business Overview
    • 10.10.2 Financial Overview
    • 10.10.3. Product Portfolio
    • 10.10.4. Strategic Developments

11. Appendix

  • 11.1. Industry Speaks
Back to Top
전화 문의
F A Q